News Conference News ACC 2025 FAIR-HF2: Another IV Iron Trial Fails to Impact Hard Endpoints While inconsistent dosing could have played a role, it still may be possible to identify the patients most likely to see benefit. L.A. McKeown April 03, 2025
Presentation ACC 2025 FAIR-HF2 Trial: Intravenous iron in patients with systolic heart failure and iron deficiency to improve morbidity & mortality Presenter: Stefan D. Anker March 30, 2025
Presentation ACC 2025 The MIGHTy-Heart Randomized Clinical Trial Presenter: Ruth Masterson Creber March 30, 2025
Presentation ACC 2025 Liberal Fluid Intake versus Fluid Restriction in Chronic Heart Failure: The FRESH-UP Study Presenter: Roland R. Van Kimmenade March 30, 2025
Presentation ACC 2025 Dapagliflozin after Transcatheter Aortic Valve Implantation Presenter: Sergio Raposeiras-Roubin March 29, 2025
News Conference News ACC 2025 FAIR-HF2: Another IV Iron Trial Fails to Impact Hard Endpoints By L.A. McKeown April 03, 2025
News Conference News ACC 2025 Tight Fluid Restriction Not Needed in Chronic HF Patients: FRESH-UP By Michael O'Riordan April 01, 2025
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for March 2025 By Caitlin E. Cox April 01, 2025
News Conference News ACC 2025 By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATE By Michael O'Riordan March 31, 2025